Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice
Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice
复制标题
白藜芦醇通过减轻 YAP 介导的神经炎症和促进小鼠海马自噬来改善脂多糖诱导的焦虑样行为
DOI:
10.1016/j.taap.2020.115261
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Junming Fan
中科院分区:
文献类型:
--
作者:
Qiuyun Tian;Xiaofang Fan;Jianshe Ma;Yujiao Han;Dantong Li;Shan Jiang;Fukun Zhang;Hui Guang;Xiaoqiong Shan;Ran Chen;Ping Wang;Qing Wang;Jinge Yang;Yongyu Wang;Lianggang Hu;Yangping Shentu;Yongsheng Gong;Junming Fan
Resveratrol, a type of natural polyphenol mainly extracted from the skin of grapes, has been reported to protect against inflammatory responses and exert anxiolytic effect. Yes-associated protein (YAP), a major downstream effector of the Hippo signalingpathway, plays a critical role in inflammation. The present study aimed to explorewhether YAP pathway was involved in the anxiolytic effect of resveratrol in lipopolysaccharide (LPS)-treated C57BL/6J male mice. LPS treatment induced anxiety-like behavior and decreased sirtuin 1 while increased YAP expression in the hippocampus. Resveratrol attenuated LPS-induced anxiety-like behavior, which was blocked by EX-527 (a sirtuin 1 inhibitor). Mechanistically, the anxiolytic effects of resveratrol were accompanied by a marked decrease in YAP, interleukin-1β and ionized calcium binding adaptor molecule 1 (Iba-1) while a significant increase in autophagic protein expression in the hippocampus. Pharmacological study using XMU-MP-1, a YAP activator, showed that activating YAP could induce anxiety-like behavior and neuro-inflammation as well as decrease hippocampal autophagy. Moreover, activation of YAP by XMU-MP-1 treatment attenuated the ameliorative effects of resveratrol on LPS-induced anxiety-like behavior, while blockade of YAP activation with verteporfin, a YAP inhibitor, attenuated LPS-induced anxiety-like behavior and neuro-inflammation as well as hippocampal autophagy. Finally, rapamycin-mediated promotion of autophagy attenuated LPS-induced anxiety-like behavior and decreased interleukin-1β and Iba-1 expression in the hippocampus. Collectively, these results indicate that amelioration by resveratrol in LPS-induced anxiety-like behavior is through attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy, and suggest that inhibof YAP pathway could be a potential therapeutic target for anxiety-like behavior induced by neuro-inflammation.